BPG is committed to discovery and dissemination of knowledge
Citation
Zhang Y, Shen JQ, Shao L, Chen Y, Lei L, Wang JL. Non-small-cell lung cancer with epidermal growth factor receptor L861Q-L833F compound mutation benefits from both afatinib and osimertinib: A case report. World J Clin Cases 2021; 9(27): 8220-8225 [PMID: 34621884 DOI: 10.12998/wjcc.v9.i27.8220]
Please LOGIN to submit a new comment.